The first two months of the US’s COVID-19 vaccination campaign saw demand far exceeding available supply, a mismatch that generated widespread frustration. However, the next three months might be about the slow pace of administration leaving millions of available doses on shelves already strained from a massive stockpile of unused inventory.
Want to see more of The Dispatch in Google search?
Add Us as a Preferred Source



